Canature Health Technology Co., Ltd. (SHE:300272)
China · Delayed Price · Currency is CNY 6.23
+0.15 (2.47%)
Aug 14, 2026, 3:04 PM CST
SHE:300272 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,809 | 4,574 | 3,475 | 3,483 | 2,949 | 4,078 | |
Market Cap Growth | -0.57% | 31.61% | -0.21% | 18.08% | -27.68% | 38.34% |
Enterprise Value | 4,227 | 4,601 | 3,639 | 3,464 | 3,090 | 4,321 |
Last Close Price | 6.23 | 7.42 | 5.95 | 5.72 | 4.71 | 6.39 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 91.14 | 81.66 | 49.37 | 26.29 | 31.86 | 38.89 |
Forward PE | - | 35.24 | 35.24 | 35.24 | 35.24 | 35.24 |
PS Ratio | 2.06 | 2.48 | 2.02 | 2.08 | 1.78 | 2.70 |
PB Ratio | 2.77 | 3.35 | 2.62 | 2.54 | 2.64 | 3.26 |
P/TBV Ratio | 3.77 | 4.56 | 3.56 | 3.32 | 3.64 | 4.55 |
P/FCF Ratio | 35.44 | 29.53 | 21.56 | 11.82 | 48.47 | 35.31 |
P/OCF Ratio | 16.08 | 15.27 | 11.90 | 9.29 | 18.98 | 21.83 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.29 | 2.50 | 2.11 | 2.07 | 1.86 | 2.86 |
EV/EBITDA Ratio | 14.68 | 17.63 | 18.02 | 16.59 | 17.00 | 23.56 |
EV/EBIT Ratio | 21.46 | 22.99 | 24.79 | 21.81 | 23.94 | 30.78 |
EV/FCF Ratio | 39.32 | 29.70 | 22.57 | 11.76 | 50.77 | 37.41 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.95 | 0.98 | 0.85 | 0.69 | 0.50 | 0.25 |
Debt / EBITDA Ratio | 4.55 | 4.63 | 4.87 | 4.03 | 2.75 | 1.63 |
Debt / FCF Ratio | 12.18 | 8.65 | 6.98 | 3.23 | 9.27 | 2.72 |
Net Debt / Equity Ratio | 0.22 | 0.17 | 0.25 | 0.04 | 0.14 | 0.03 |
Net Debt / EBITDA Ratio | 1.19 | 0.87 | 1.62 | 0.27 | 0.83 | 0.18 |
Net Debt / FCF Ratio | 2.87 | 1.47 | 2.03 | 0.19 | 2.48 | 0.28 |
Asset Turnover | 0.56 | 0.53 | 0.55 | 0.63 | 0.74 | 0.77 |
Inventory Turnover | 4.22 | 4.07 | 4.22 | 3.70 | 3.62 | 4.07 |
Quick Ratio | 0.74 | 0.76 | 0.84 | 0.98 | 0.74 | 0.89 |
Current Ratio | 0.94 | 0.94 | 1.06 | 1.22 | 1.12 | 1.31 |
Return on Equity (ROE) | 4.63% | 5.95% | 7.43% | 12.33% | 8.36% | 9.49% |
Return on Assets (ROA) | 3.75% | 3.58% | 2.91% | 3.72% | 3.61% | 4.44% |
Return on Invested Capital (ROIC) | 8.39% | 8.97% | 7.85% | 11.39% | 8.76% | 8.77% |
Return on Capital Employed (ROCE) | 10.60% | 10.80% | 7.20% | 8.60% | 9.00% | 10.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.06% | 1.23% | 2.02% | 3.80% | 3.14% | 2.57% |
FCF Yield | 2.82% | 3.39% | 4.64% | 8.46% | 2.06% | 2.83% |
Dividend Yield | 2.89% | 2.43% | 2.69% | 1.75% | 2.12% | 1.57% |
Payout Ratio | 334.73% | 236.69% | 258.85% | 59.01% | 75.48% | 38.97% |
Buyback Yield / Dilution | -4.45% | -1.34% | 0.03% | -1.19% | 2.82% | -10.26% |
Total Shareholder Return | -1.49% | 1.08% | 2.72% | 0.56% | 4.94% | -8.69% |